UK markets closed

CRISPR Therapeutics AG (CRSP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
53.81+0.82 (+1.55%)
At close: 04:00PM EDT
53.88 +0.07 (+0.13%)
After hours: 04:22PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
370,000
370,000
436
913,081
543
Cost of revenue
130,250
130,250
110,250
101,178
-
Gross profit
239,750
239,750
-109,814
811,903
-
Operating expenses
Research development
387,332
387,332
461,645
340,567
266,946
Selling general and administrative
76,162
76,162
102,464
99,690
88,208
Total operating expenses
462,288
462,288
563,347
438,375
354,978
Operating income or loss
-222,538
-222,538
-673,161
373,528
-354,435
Total other income/expenses net
71,816
71,816
22,661
6,003
6,379
Income before tax
-150,722
-150,722
-650,500
379,531
-348,056
Income tax expense
2,888
2,888
-325
1,870
809
Income from continuing operations
-153,610
-153,610
-650,175
377,661
-348,865
Net income
-153,610
-153,610
-650,175
377,661
-348,865
Net income available to common shareholders
-153,610
-153,610
-650,175
377,661
-348,865
Basic EPS
-5.29
-1.94
-8.36
4.97
-5.29
Diluted EPS
-5.29
-1.94
-8.36
4.70
-5.29
Basic average shares
65,950
79,221
77,747
75,949
65,950
Diluted average shares
65,950
79,221
77,747
80,393
65,950